Neurocrine Biosciences (NBIX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec9

Neurosecretion Biopharma to Host 2025 R&D Day on December 16

21:01

Dec6

TD Cowen Raises Neurocrine Biosciences Target Price to $200

17:56

Dec3

Russell Investments Reduces Holdings in Neurosign Bioscience

10:51

Dec2

Neurosecretion Biotech's CBO Disposes of Common Stock

22:22

Nov26

George J Moro Reports Disposition of Neurosecretion Biotech Corp Common Stock

21:28

Nov20

Neuronascent Bioscience Announces Publication of Narrative Review on FDA-Approved VMAT2 Inhibitors

13:54

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 794.9 M, Net Income 209.5 M, EPS 2.04

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 687.5 M, Net Income 107.5 M, EPS 1.06

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 572.6 M, Net Income 7.9 M, EPS 0.0792

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More